Expeditors 'adapted well in an erratic quarter' – but earnings disappoint
Expeditors’ Q2 results will have left investors disappointed, with softer-than-expected earnings and a “still-heavy” cost ...
ID 32151428 © Flynt | Dreamstime.com
From Premium’s smell of blood in October to new records: it has been a hell of a ride for Expeditors (EXPD) in recent weeks.
Since 7 November, when it disclosed a mixed Q3 23 trading update, it has gained traction without leaving a cent on the ground in terms of capital appreciation.
Stunning.
Spare a thought for its detractors: seldom more expensive, based on its forward twelve months multiples – and when it was just as pricey as it is now (click to ...
Comment on this article